Skip to content

DOKTER JAN OOSTERBOSCH

Active Private limited company (pre-2019)founded 1996active for 29 yearsStrippestraat 20, 3600 GenkKBO/BCE: BE 0459.466.135

Lifetime

23 annual accounts with figures on one time axis, 29 filings since 1997
peak of €240,266 in 2018
€35,016▼ 58.8%
peak of €148,143 in 2023
€9,708▼ 79.3%
peak of €898,935 in 2020
€658,321▼ 6.5%
€133,400▼ 18.3%
Board1 name since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €85,037 to €35,016Result from €46,844 to €9,708Dividend €55,561Debts from €163,354 to €133,400

Key points

from the 2025 annual accounts

Equity

€658,321 ▼ 6.5%
704,1742024+9,708Profit-55,561Dividend658,3212025

DOKTER JAN OOSTERBOSCH paid out €55,561 in dividends. That is 572% of the 2025 profit.

Filings

29 annual accounts since 1997
AprilJune31 JulyOctober200020102020

Ten of the last ten came late. The 2025 accounts came in latest, 31 days after the end of the period.

Position in the sector

€9,708

Lower net result than 83% of companies in human health. The sector median is €59,520, over 21,372 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 14,780 companies had the same profile as DOKTER JAN OOSTERBOSCH has now. Each dot stands for 37 companies, two years later.

96.2%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 14,780 companies, not a prediction for DOKTER JAN OOSTERBOSCH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0459466135
Incorporation · Founder Gazette deed
Incorporation published on 24-12-1996 · Gazette deed
First establishment Strippestraat 20, Genk
All 37 events

Comparable companies

same main activity, similar in size and age
Company
DOKTER JAN OOSTERBOSCH Genk €791,721 €35,016 83.2% -
Dokter A. Van Hoof Bruges €868,419 €31,976 98.8% -
Lipocentrum Belgique Lanaken €590,282 €37,773 9.6% -
DOKTER GYSELAERS Genk €470,919 €37,399 46.7% -
Dokter Katleen Hendrikx Pelt €754,901 €42,792 24.7% -
DOKTER D. PLATEVOET Sint-Martens-Latem €544,322 €33,348 91.1% -
DOKTER L. SEYNAEVE Roeselare €748,003 €38,697 99.4% -

These companies have the same main activity as DOKTER JAN OOSTERBOSCH: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €471,000 and €868,000, founded between 1996 and 2007.

Official details

Source: KBO
Status
Active since 16-12-1996Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.344.606.9923600 Genk, since 10-12-1996
Financial year end
31 December
Peppol
Reachable since 16-09-2025
Company details

Annual accounts 2025

≈ €110,000estimated
€791,721▼ 8.7%
Filing
Filed on 31-08-2026
Financials

Insights on DOKTER JAN OOSTERBOSCH

DOKTER JAN OOSTERBOSCH files the micro format. That format states no turnover. The gross margin fell from €203,201 in 2002 to €35,016 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTER JAN OOSTERBOSCH

What is the company number of DOKTER JAN OOSTERBOSCH?
The company number of DOKTER JAN OOSTERBOSCH is 0459.466.135. The VAT number is the same number with BE in front: BE 0459.466.135.
Where is DOKTER JAN OOSTERBOSCH based?
The registered office is at Strippestraat 20, 3600 Genk.Company details
What does DOKTER JAN OOSTERBOSCH do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER JAN OOSTERBOSCH?
DOKTER JAN OOSTERBOSCH is a private limited company (pre-2019) (BVBA).
When was DOKTER JAN OOSTERBOSCH founded?
DOKTER JAN OOSTERBOSCH was founded on 16-12-1996.
Is DOKTER JAN OOSTERBOSCH still active?
Yes, DOKTER JAN OOSTERBOSCH is an active enterprise in the KBO register.
What is the turnover of DOKTER JAN OOSTERBOSCH?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €35,016 and 47 comparable companies (NACE 86). It probably lies between €78,000 and €150,000.Financials
Is DOKTER JAN OOSTERBOSCH profitable?
In financial year 2025, DOKTER JAN OOSTERBOSCH made a profit of €9,708.
Where can I find the annual accounts of DOKTER JAN OOSTERBOSCH?
DOKTER JAN OOSTERBOSCH filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER JAN OOSTERBOSCH due?
DOKTER JAN OOSTERBOSCH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.